SEPTEMBER 18, 2024 | HARVARD CLUB, 35 W. 44TH ST., NEW YORK CITY | 10 AM – 1 PM
Harnessing the Power of
the Immune System – R&D Day
COMPANY OVERVIEW
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies.
OUR MISSION AND VALUES
50
combined years of leadership experience in the biotech industry
15+
key partners, including the world’s most respected research institutions
5
products in the pipeline with an addressable market worth $15B+
Presenters Include:
THOUGHT LEADERS IN GYNECOLOGIC ONCOLOGY
OVATION 2 PHASE 2 STUDY INVESTIGATORS
IMUNON MANAGEMENT
Join the event
Complete the form to secure your spot in the R&D Day.
Days
Hours
Minutes
Seconds
IMUNON is developing new medicines that harness the building blocks of life to work in harmony with the body’s immune system.
Nasdaq: IMNN
©2024 Imunon. All rights reserved. Privacy Policy
General Information
Investor Relations
Event Inquiry
